• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清总胆红素水平与进行性肾衰退和终末期肾病的关系:日本糖尿病患者的 10 年观察性队列研究。

Association of serum total bilirubin levels with progressive renal decline and end-stage kidney disease: 10-year observational cohort study in Japanese patients with diabetes.

机构信息

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.

出版信息

PLoS One. 2022 Jul 12;17(7):e0271179. doi: 10.1371/journal.pone.0271179. eCollection 2022.

DOI:10.1371/journal.pone.0271179
PMID:35819962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9275719/
Abstract

OBJECTIVE

Previous reports have demonstrated the association of serum bilirubin levels with the progression of diabetic nephropathy. The objective of this study is to assess the association of basal bilirubin levels with progressive renal decline (PRD) and end-stage kidney disease (ESKD).

METHODS

A total of 298 patients with diabetes who visited Kyushu University Hospital (Japan) were recruited and followed up for 10 years. PRD was defined as a negative change in estimated glomerular filtration ratio (eGFR) >3.7%/year, 2.5th percentile. Logistic regression analysis was performed to evaluate the association of total bilirubin levels with PRD and its cut-off point was determined by receiver operating characteristic (ROC) analysis. Kaplan-Meier method and Cox hazard regression analysis were used to evaluate the predictive ability of its cut-off point for ESKD.

RESULTS

Logistic regression model showed that total bilirubin levels were significantly associated with PRD, and ROC analysis showed that its cut-off point was 0.5 mg/dL. Kaplan-Meier method showed that the percent of patients who reached two endpoints, composite endpoint (ESKD or doubling of creatinine level) or 30% eGFR decline, was significantly higher in the low bilirubin group than in the high bilirubin group (18.5% vs 11.0%, P = 0.045; 49.1% vs 42.1%, P = 0.045, respectively, log-rank test). Cox hazard regression models confirmed the independence of the predictive ability of its cut-off point.

CONCLUSIONS

Serum total bilirubin levels were negatively associated with PRD in diabetic nephropathy and its cut-off point was 0.5 mg/dL. It may be clinically useful for identifying patients at high risk of ESKD.

摘要

目的

先前的报告表明血清胆红素水平与糖尿病肾病的进展有关。本研究旨在评估基础胆红素水平与进行性肾下降(PRD)和终末期肾病(ESKD)的相关性。

方法

共招募了 298 名在日本九州大学医院就诊的糖尿病患者,随访 10 年。PRD 定义为估算肾小球滤过率(eGFR)的负变化>3.7%/年,第 2.5 百分位。使用逻辑回归分析评估总胆红素水平与 PRD 的相关性,并通过接收者操作特征(ROC)分析确定其截断点。使用 Kaplan-Meier 方法和 Cox 风险回归分析评估其截断点对 ESKD 的预测能力。

结果

逻辑回归模型表明,总胆红素水平与 PRD 显著相关,ROC 分析表明其截断点为 0.5mg/dL。Kaplan-Meier 方法表明,在低胆红素组中达到两个终点(ESKD 或肌酐水平翻倍)或 eGFR 下降 30%的患者比例明显高于高胆红素组(18.5%比 11.0%,P=0.045;49.1%比 42.1%,P=0.045,分别为对数秩检验)。Cox 风险回归模型证实了其截断点的预测能力的独立性。

结论

血清总胆红素水平与糖尿病肾病的 PRD 呈负相关,其截断点为 0.5mg/dL。它可能对识别 ESKD 高危患者具有临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c8/9275719/62d5f6c8b95f/pone.0271179.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c8/9275719/b28c91e2920d/pone.0271179.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c8/9275719/62d5f6c8b95f/pone.0271179.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c8/9275719/b28c91e2920d/pone.0271179.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c8/9275719/62d5f6c8b95f/pone.0271179.g002.jpg

相似文献

1
Association of serum total bilirubin levels with progressive renal decline and end-stage kidney disease: 10-year observational cohort study in Japanese patients with diabetes.血清总胆红素水平与进行性肾衰退和终末期肾病的关系:日本糖尿病患者的 10 年观察性队列研究。
PLoS One. 2022 Jul 12;17(7):e0271179. doi: 10.1371/journal.pone.0271179. eCollection 2022.
2
One-year estimated glomerular filtration rate decline as a risk factor of cardiovascular and renal end-points in high-risk Japanese patients.在高危日本患者中,估算肾小球滤过率下降 1 年作为心血管和肾脏终点的风险因素。
J Diabetes Investig. 2021 Jul;12(7):1212-1219. doi: 10.1111/jdi.13474. Epub 2020 Dec 30.
3
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.非白蛋白尿性慢性肾脏病向终末期肾病进展的风险:CRIC(慢性肾功能不全队列)研究。
Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18.
4
Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.血清胆红素水平降低与 IgA 肾病患者的肾脏预后不良相关。
Int J Med Sci. 2021 Jun 11;18(13):2964-2970. doi: 10.7150/ijms.60111. eCollection 2021.
5
Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.估算肾小球滤过率下降与2型糖尿病合并大量白蛋白尿患者的终末期肾病风险相关:一项来自日本糖尿病肾病协作研究(JDNCS)的观察性研究
Clin Exp Nephrol. 2018 Apr;22(2):377-387. doi: 10.1007/s10157-017-1467-9. Epub 2017 Sep 9.
6
A simplified prediction model for end-stage kidney disease in patients with diabetes.用于预测糖尿病患者终末期肾病的简化模型。
Sci Rep. 2022 Jul 21;12(1):12482. doi: 10.1038/s41598-022-16451-5.
7
THE ASSOCIATION OF SERUM BILIRUBIN ON KIDNEY CLINICOPATHOLOGIC FEATURES AND RENAL OUTCOME IN PATIENTS WITH DIABETIC NEPHROPATHY: A BIOPSY-BASED STUDY.血清胆红素与糖尿病肾病患者肾脏临床病理特征及肾脏结局的关系:一项基于肾活检的研究。
Endocr Pract. 2019 Jun;25(6):554-561. doi: 10.4158/EP-2018-0560. Epub 2019 Mar 13.
8
Serum bilirubin concentration is associated with eGFR and urinary albumin excretion in patients with type 1 diabetes mellitus.1型糖尿病患者的血清胆红素浓度与估算肾小球滤过率及尿白蛋白排泄相关。
J Diabetes Complications. 2015 Nov-Dec;29(8):1223-7. doi: 10.1016/j.jdiacomp.2015.07.007. Epub 2015 Jul 9.
9
Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.镜下血尿是经肾活检证实的糖尿病肾病患者发生终末期肾病的一个危险因素。
BMJ Open Diabetes Res Care. 2020 Nov;8(2). doi: 10.1136/bmjdrc-2020-001863.
10
Temporal alteration of serum bilirubin levels and its renoprotective effects in diabetic kidney disease: exploring the hormonal mechanisms.血清胆红素水平的时间变化及其在糖尿病肾病中的肾脏保护作用:探讨激素机制。
Front Endocrinol (Lausanne). 2024 May 1;15:1361840. doi: 10.3389/fendo.2024.1361840. eCollection 2024.

引用本文的文献

1
Association of Serum Total Bilirubin to Cholesterol Ratio With Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes: A Retrospective Cohort Study.2型糖尿病患者血清总胆红素与胆固醇比值与慢性肾脏病进展的关联:一项回顾性队列研究
J Diabetes. 2025 May;17(5):e70097. doi: 10.1111/1753-0407.70097.
2
The impact of brominated flame retardants exposure on serum total bilirubin: A cross-sectional analysis.溴化阻燃剂暴露对血清总胆红素的影响:一项横断面分析。
PLoS One. 2025 Mar 28;20(3):e0320523. doi: 10.1371/journal.pone.0320523. eCollection 2025.
3
Exploring the inverse relationship between serum total bilirubin and systemic immune-inflammation index: insights from NHANES data (2009-2018).

本文引用的文献

1
11. Microvascular Complications and Foot Care: .11. 微血管并发症和足部护理: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S151-S167. doi: 10.2337/dc21-S011.
2
Serum bilirubin level is a strong predictor for disability in activities in daily living (ADL) in Japanese elderly patients with diabetes.血清胆红素水平是预测日本老年糖尿病患者日常生活活动(ADL)能力障碍的一个强有力指标。
Sci Rep. 2019 May 8;9(1):7069. doi: 10.1038/s41598-019-43543-6.
3
Bilirubin as an important physiological modulator of oxidative stress and chronic inflammation in metabolic syndrome and diabetes: a new aspect on old molecule.
探讨血清总胆红素与全身免疫炎症指数之间的负相关关系:来自 NHANES 数据(2009-2018 年)的见解。
Eur J Med Res. 2024 Jul 12;29(1):362. doi: 10.1186/s40001-024-01963-9.
4
Total bilirubin level is associated with acute kidney injury in neonates admitted to the neonatal intensive care units: based on MIMIC-III database.总胆红素水平与新生儿重症监护病房新生儿急性肾损伤相关:基于 MIMIC-III 数据库。
Eur J Pediatr. 2024 Oct;183(10):4235-4241. doi: 10.1007/s00431-024-05682-5. Epub 2024 Jul 11.
5
A Novel Kidney Failure Prediction Model in Individuals With CKD: Impact of Serum Bilirubin Levels.慢性肾脏病患者的新型肾衰竭预测模型:血清胆红素水平的影响
J Clin Endocrinol Metab. 2025 Apr 22;110(5):1375-1383. doi: 10.1210/clinem/dgae430.
6
Temporal alteration of serum bilirubin levels and its renoprotective effects in diabetic kidney disease: exploring the hormonal mechanisms.血清胆红素水平的时间变化及其在糖尿病肾病中的肾脏保护作用:探讨激素机制。
Front Endocrinol (Lausanne). 2024 May 1;15:1361840. doi: 10.3389/fendo.2024.1361840. eCollection 2024.
7
Association between serum total bilirubin and diabetic kidney disease in US diabetic patients.血清总胆红素与美国糖尿病患者糖尿病肾病的相关性。
Front Endocrinol (Lausanne). 2023 Dec 12;14:1310003. doi: 10.3389/fendo.2023.1310003. eCollection 2023.
8
Association of Serum Bilirubin Levels with Macro- and Microvascular Complications in Chinese People with Type 2 Diabetes Mellitus: New Insight on Gender Differences.中国2型糖尿病患者血清胆红素水平与大血管及微血管并发症的关联:关于性别差异的新见解
Diabetes Metab Syndr Obes. 2023 Mar 4;16:597-606. doi: 10.2147/DMSO.S403483. eCollection 2023.
胆红素作为代谢综合征和糖尿病中氧化应激及慢性炎症的重要生理调节因子:旧分子的新视角
Diabetol Int. 2016 Sep 21;7(4):338-341. doi: 10.1007/s13340-016-0288-5. eCollection 2016 Dec.
4
Effect of bilirubin concentration on the risk of diabetic complications: A meta-analysis of epidemiologic studies.胆红素浓度对糖尿病并发症风险的影响:一项流行病学研究的荟萃分析。
Sci Rep. 2017 Jan 30;7:41681. doi: 10.1038/srep41681.
5
A Novel Perspective on the Biology of Bilirubin in Health and Disease.胆红素在健康与疾病中的生物学:新视角
Trends Mol Med. 2016 Sep;22(9):758-768. doi: 10.1016/j.molmed.2016.07.004. Epub 2016 Aug 8.
6
Association of serum total bilirubin with renal outcome in Japanese patients with stages 3-5 chronic kidney disease.日本3-5期慢性肾脏病患者血清总胆红素与肾脏结局的关联
Metabolism. 2015 Sep;64(9):1096-102. doi: 10.1016/j.metabol.2015.06.006. Epub 2015 Jun 14.
7
Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.进行性肾脏衰退:1型糖尿病中糖尿病肾病的新范式
Diabetes Care. 2015 Jun;38(6):954-62. doi: 10.2337/dc15-0184.
8
Association between serum bilirubin and estimated glomerular filtration rate among elderly persons.老年人血清胆红素与估计肾小球滤过率之间的关联。
PLoS One. 2014 Dec 16;9(12):e115294. doi: 10.1371/journal.pone.0115294. eCollection 2014.
9
GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.肾小球滤过率下降作为 CKD 临床试验的终点:由美国国家肾脏基金会和美国食品药品监督管理局赞助的科学研讨会。
Am J Kidney Dis. 2014 Dec;64(6):821-35. doi: 10.1053/j.ajkd.2014.07.030. Epub 2014 Oct 16.
10
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.估算肾小球滤过率下降与终末期肾病及死亡风险的相关性。
JAMA. 2014 Jun 25;311(24):2518-2531. doi: 10.1001/jama.2014.6634.